Cargando…
Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer
According to current guidelines, all women with epithelial ovarian cancer are eligible for genetic testing for BRCA germline pathogenic variants. Unfortunately, not all affected women are tested. We evaluated the acceptability and feasibility for non-genetic healthcare professionals to incorporate g...
Autores principales: | Bokkers, Kyra, Zweemer, Ronald P., Koudijs, Marco J., Stehouwer, Sanne, Velthuizen, Mary E., Bleiker, Eveline M. A., Ausems, Margreet G. E. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203381/ https://www.ncbi.nlm.nih.gov/pubmed/34617209 http://dx.doi.org/10.1007/s10689-021-00277-7 |
Ejemplares similares
-
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing
por: Bokkers, Kyra, et al.
Publicado: (2022) -
The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review
por: Bokkers, Kyra, et al.
Publicado: (2022) -
ASO Author Reflections: The Role of Surgeons and Nurse Specialists in the Mainstreaming of Genetic Testing for Breast Cancer Patients
por: Bokkers, Kyra, et al.
Publicado: (2023) -
Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences
por: Velthuizen, Mary E., et al.
Publicado: (2021) -
Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study
por: Vlaming, Michiel, et al.
Publicado: (2022)